Lobular Carcinoma of the Breast and Utility of Oncotype Dx®: a Retrospective Decision Impact Analysis.

MLA

Barni, Sandro, et al. “Lobular Carcinoma of the Breast and Utility of Oncotype Dx®: A Retrospective Decision Impact Analysis.” Clinical Breast Cancer, vol. 23, no. 3, Apr. 2023, pp. e173–74. EBSCOhost, https://doi.org/10.1016/j.clbc.2022.12.005.

APA

Barni, S., Fabi, A., & Petrelli, F. (2023). Lobular Carcinoma of the Breast and Utility of Oncotype Dx®: a Retrospective Decision Impact Analysis. Clinical Breast Cancer, 23(3), e173–e174. https://doi.org/10.1016/j.clbc.2022.12.005

Chicago

Barni, Sandro, Alessandra Fabi, and Fausto Petrelli. 2023. “Lobular Carcinoma of the Breast and Utility of Oncotype Dx®: A Retrospective Decision Impact Analysis.” Clinical Breast Cancer 23 (3): e173–74. doi:10.1016/j.clbc.2022.12.005.